All relevant data are within the manuscript and its Supporting Information files.

Introduction {#sec001}
============

Hypoxic--ischemic brain injury (HIBI) occurs secondary to multiple events that cause hypoxia or hypoperfusion like cardiac arrest, respiratory failure, hanging, drowning or severe hypotension as a result of oxygen and nutrient deprivation \[[@pone.0226295.ref001]\]. Despite recent heath care advances, HIBI remains one of the principle causes of death and long-term disability worldwide. Specifically, the toll of the neurological recovery, possible complications and rehabilitation imposes a huge socioeconomic burden on individuals as well as the health care system as a whole \[[@pone.0226295.ref002], [@pone.0226295.ref003]\]. Therefore, identifying patients who can likely achieve a favorable or poor neurological outcome will significantly impact the patient prognosis and facilitate informed health care decisions.

Diminished brain-stem or extensor reflex, day three motor response, and day one cortical somatosensory evoked potentials (SSEPs), as well as serum neuron specific enolase (NSE) during the first three days and early myoclonic status epilepticus were used to predict poor HIBI outcome \[[@pone.0226295.ref004]--[@pone.0226295.ref006]\]. However, the emerging use of therapeutic hypothermia for the management of comatose cardiac arrest patients has decreased the utility of the above mentioned markers\[[@pone.0226295.ref007]--[@pone.0226295.ref010]\]. Particularly, therapeutic hypothermia involves the use of sedatives and neuromuscular blockers during the induction and normothermia phases which render the prognostic predictors less reliable, especially those based on clinical examination \[[@pone.0226295.ref007], [@pone.0226295.ref011]\]. Therefore, developing a more accurate assessment of early-stage HIBI patients is urgently needed.

Neuroimaging approaches like magnetic resonance imaging (MRI), Diffusion-weighted imaging (DWI), and computed tomography (CT) are commonly used diagnostic techniques for exploring brain structure and function \[[@pone.0226295.ref012]\]. Nevertheless, CT and conventional MRI frequently underestimate the degree of brain injury in acute HIBI \[[@pone.0226295.ref013], [@pone.0226295.ref014]\]. On the other hand, DWI provides a more accurate diagnostic alternative in acute or subacute HIBI \[[@pone.0226295.ref015]\] and enables precise estimation of disease degree by calculating the apparent diffusion coefficient (ADC) \[[@pone.0226295.ref016], [@pone.0226295.ref017]\]. Moreover, DWI has been proven valuable in therapeutic hypothermia or sedated patients \[[@pone.0226295.ref018], [@pone.0226295.ref019]\]. Previous studies have investigated the diagnostic and prognostic value of DWI in HIBI; however, the sensitivity and specificity of DWI as a clinical tool were inconsistent among the different studies \[[@pone.0226295.ref014], [@pone.0226295.ref020]--[@pone.0226295.ref022]\]. In this study, we performed a meta-analysis of previously published literature to re-evaluate the diagnostic value of DWI in predicting HIBI outcomes.

Methods {#sec002}
=======

Study design {#sec003}
------------

In this study, we performed a comprehensive literature research in PubMed, EMBASE, and the Cochrane Library databases for DWI from January 1995 to September 2019. We examined the diagnostic value of DWI in predicting HIBI outcomes using the following keywords: ("diffusion-weighted magnetic resonance images" or "diffusion magnetic resonance" or "DW-MRI" or "DW magnetic resonance images" or "diffusion-weighted imaging" or "diffusion MRI" or diffusion-weighted MRI") and ("anoxia" or "ischemia" or "hypoxia" or "heart arrest" or "cardiac arrest" or "postoperative complication" or "respiratory insufficiency" or "resuscitation" or "drowning") and ("prognosis" or "outcome"). In addition, we also examined the reference section of all examined articles for additional reports. In some cases, we had to contact the corresponding authors to seek the original data sets if the necessary information could not be extracted online. From each study, we gathered and analyzed the following information: patients' baseline demographic characteristics (gender, age, hypothermia treatment and outcome assessment), study design (prospective or retrospective), experimental protocol, elapsed interval between HIBI and brain MRI, DWI imaging protocol (magnetic field strength, b-value, and positive indices), and the diagnostic results (i.e. the true-positive, false-positive, false-negative, and true-negative results).

In order to investigate the predictive power of DWI on HIBI outcome, we only analyzed studies that examined the neurological outcome in terms of the five cerebral performance categories (CPCs) or an equivalent \[[@pone.0226295.ref005], [@pone.0226295.ref023]\]. A CPC score of 1 indicated full recovery; 2 indicated moderate disability, 3 indicated severe neurological disability with preserved consciousness, 4 indicated comatose or vegetative state patients, 5 indicated death. Next, the outcome was classified into poor and good according to the CPC scores (3--4 or 4--5 versus1-2 or 1--3, respectively).

Inclusion and exclusion criteria {#sec004}
--------------------------------

The inclusion criteria included English language clinical prognostic DWI articles that were published in indexed journals and studies investigating adult HIBI patients (\>/ = 14 years). Also, we included studies reporting various causes of HIBI, provided that each condition resulted in the common endpoint of generalized cerebral hypoxia or global hypoperfusion. Finally, only studies with complete data sets (i.e.the number of true/false negatives and positives for poor outcome prediction) were included. This was essential to enable the calculation of outcome variables with confidence intervals (CIs). Exclusion criteria included published abstracts, case reports, review articles and studies involving 10 patients or less, as well as patients with HIBI secondary to stroke, trauma, intracranial infection, sepsis, and/or metabolic dysfunction.

We confirmed the quality of the included studies using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool as detailed previously \[[@pone.0226295.ref024]\]. Two primary investigators were responsible for data collection and quality assessment in an independent manner.

Statistical analysis {#sec005}
--------------------

A Chi-square test and the inconsistency index (I^2^) were used to estimate the heterogeneity between enrolled studies. A P \< 0.1 or I^2^ \> 50% indicated the presence of heterogeneity\[[@pone.0226295.ref025]\]. If heterogeneity was recorded, a binary regression model with random coefficients was used to determine the diagnostic performance \[[@pone.0226295.ref026]\]. The summary receiver operating characteristic (SROC) curve, and area under the curve (AUC) were used to predict the outcome of HIBI \[[@pone.0226295.ref027]\].

The threshold effect was determined from the "shoulder-arm" shape of the ROC curve \[[@pone.0226295.ref028]\]. A correlation between the logit of sensitivity and the logit of (1---specificity) was computed by the Spearman correlation coefficient to assess the existence of a threshold effect, and a P \< 0.05 indicated a positive threshold effect \[[@pone.0226295.ref029]\]. Next, we performed a meta-regression analysis and subgroup analysis to investigate factors that could possibly lead to heterogeneity and explored their possible impact on diagnostic accuracy \[[@pone.0226295.ref030]\].

The analysis of heterogeneity test, the threshold effect and the diagnostic performance, as well as meta-regression and subgroup analyses were all carried out by Meta-DiSc (version 1.4) \[[@pone.0226295.ref031]\]. On the other hand, publication bias was assessed by an asymmetry test and Deeks' funnel plot using Stata (version 12.0). An inverted symmetrical funnel plot with P \> 0.05 indicated the lack of publication bias \[[@pone.0226295.ref032]\].

Results {#sec006}
=======

From January 1995 to September 2019, we collected a total of 4042 records from the different data bases. After applying the inclusion and exclusion criteria, a total of 28 studies were included in this meta-analysis ([Fig 1](#pone.0226295.g001){ref-type="fig"}).

![Flow chart representing the scheme of our study design.](pone.0226295.g001){#pone.0226295.g001}

Study features and quality assessment {#sec007}
-------------------------------------

The clinical features and baseline characters of patients in each study examined are presented in [Table 1](#pone.0226295.t001){ref-type="table"}. A total of 1,645 patients (age range between 14 and 89 years) were enrolled from the 28 studies. The average number of patients in each included study was 59 (range 14--172). Among the investigated studies, 14 were conducted prospectively and the remaining 14 studies were retrospective. Five studies collected data from out-of-hospital cardiac arrest (OHCA) patients, while the other 23 studies included OHCA and in-hospital cardiac arrest (IHCA) patients. Hypothermia treatment was administered to all patients in 11 studies (n = 600), and only some patients in the other 13 studies (n = 551). In the remaining 4 studies, hypothermia treatment was not offered or not mentioned to patients (n = 90). Outcome was assessed at hospital discharge, death or within several weeks in 8 studies; at 3 months in 2 studies, and at 6 months or more in 18 studies. A poor outcome was defined as CPC 3--5 in 14 studies or as CPC 4--5 in another 10 studies, and according to other scoring systems in the remaining 4 studies.

10.1371/journal.pone.0226295.t001

###### Study designs and baseline patient characteristics.

![](pone.0226295.t001){#pone.0226295.t001g}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year, reference                         Type    IHCA or OHCA   No. of patients   Males, %     Mean age, years \[±SD\] or median (IQR range)   Treatment with\   Definition of poor outcome   Timing of outcome assessment
                                                                                                                                                        hypothermia                                    
  ----------------------------------------------- ------- -------------- ----------------- ------------ ----------------------------------------------- ----------------- ---------------------------- ------------------------------
  Barrett,2007^\[^[@pone.0226295.ref033]^\]^      Retro   Mix            18                10(56%)      62 (49\~73)                                     no                CPC3-5                       Death or hospital discharge

  Bevers,2018^\[^[@pone.0226295.ref034]^\]^       Retro   Mix            78                49(63%)      53 ± 17                                         yes               CPC4,5                       hospital discharge

  Choi,2010 ^\[^[@pone.0226295.ref035]^\]^        Pro     OHCA           39                28(71.8%)    49.1(18\~89)                                    15/39             CPC3-5                       3 months

  Choi,2018 ^\[^[@pone.0226295.ref036]^\]^        Pro     Mix            14                10(71.4%)    43.4 ± 15.6                                     8/14              CPC 3--5                     at discharge.

  Cronberg,2011 ^\[^[@pone.0226295.ref037]^\]^    Pro     Mix            22                N/A          N/A                                             yes               CPC4-5                       6 months

  Els,2004 ^\[^[@pone.0226295.ref014]^\]^         Pro     Mix            12                N/A          53 (27\~71)                                     no                CPC4-5                       6 months

  Greer,2012 ^\[^[@pone.0226295.ref038]^\]^       Retro   Mix            80                49(61%)      57±16                                           14/80             mRS5                         3 months

  Greer,2013 ^\[^[@pone.0226295.ref039]^\]^       Pro     Mix            80                49(61%)      62 (IQR 46--70)                                 14/80             mRS4-5                       6 months

  Hirsch,2015 ^\[^[@pone.0226295.ref040]^\]^      Pro     Mix            68                44(64.7%)    56 ± 15                                         37/68             CPC4-5                       6 months

  Hirsch,2016^\[^[@pone.0226295.ref022]^\]^       Retro   Mix            125               82(66%)      58 ± 16                                         77/125            CPC4-5                       Day 14 or\
                                                                                                                                                                                                       at discharge

  Jarnum,2009 ^\[^[@pone.0226295.ref018]^\]^      Pro     Mix            20                11(55%)      57.8(14\~81)                                    yes               CPC3-5                       6 months

  Jeon,2017 ^\[^[@pone.0226295.ref041]^\]^        Retro   Mix            39                27 (69%)     52.2±16.5                                       yes               CPC3-5                       6 months

  Kim,2012^\[^[@pone.0226295.ref042]^\]^          Retro   OHCA           43                29(67.4%)    57±17.6\                                        yes               CPC3-5                       6 months

  Kim,2013^\[^[@pone.0226295.ref043]^\]^          Retro   OHCA           51                38 (74.5)    63(IQR, 42--72)                                 45/51             CPC3-5                       6 months

  Kim,2016^\[^[@pone.0226295.ref044]^\]^          Retro   OHCA           110               83(75.5%)    59 (47--70)                                     100/110           CPC3-5                       6 months

  Luyt,2012^\[^[@pone.0226295.ref045]^\]^         Pro     Mix            57                40 (70%)     52 ± 18                                         36 /57            GOS-E1-4                     12 months

  Mettenburg,2016^\[^[@pone.0226295.ref046]^\]^   Retro   Mix            33                N/A          54(24--80)                                      yes               CPC4,5                       at discharge

  Mlynash,2010^\[^[@pone.0226295.ref047]^\]^      Pro     Mix            32                23(72%)      55.5±17.3                                       21/32             CPC4-5                       6 months

  Moon,2018^\[^[@pone.0226295.ref048]^\]^         Pro     Mix            96                66 (68%)     52±16                                           yes               CPC3-5                       6 months

  Oren,2019^\[^[@pone.0226295.ref049]^\]^         Retro   Mix            38                20(52.6%)    52.8(18--87)                                    N/A               CPC4-5                       6 months

  Park,2015^\[^[@pone.0226295.ref050]^\]^         Pro     Mix            19                16(84.2%)    54.6±18.7                                       yes               CPC3-5                       at discharge

  Reynolds,2017^\[^[@pone.0226295.ref051]^\]^     Retro   Mix            69                37(54%)      60 (IQR 50, 73)                                 60/69             CPC3-5                       at discharge

  Ryoo,2015^\[^[@pone.0226295.ref052]^\]^         Retro   OHCA           172               117(68.0%)   54.7 ± 16.0                                     yes               CPC3-5                       at discharge

  Topcuoglu,2009^\[^[@pone.0226295.ref053]^\]^    Retro   Mix            22                14(61%)      56±16.9                                         no                CPC4-5                       6 months

  Velly,2018^\[^[@pone.0226295.ref054]^\]^        Pro     Mix            150               97 (65%)     51 ±16                                          110/150           CPC3-5                       6 months

  Wallin,2018^\[^[@pone.0226295.ref055]^\]^       Pro     Mix            46                31 (67%)     68 (IQR 59--76)                                 yes               CPC3-5                       6 months

  Wijman,2009^\[^[@pone.0226295.ref019]^\]^       Pro     Mix            32                N/A          N/A                                             yes               CPC4-5                       6-month

  Wu,2009^\[^[@pone.0226295.ref021]^\]^           Retro   Mix            80                49(61%)      57±16                                           14/80             mRS4-5                       6 months
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Note**: N/A = data unavailable; Retro = retrospective study; Pro = prospective study; OHCA = out-of-hospital cardiac arrest; IHCA = in-hospital cardiac arrest; Mix = OHCA or IHCA; CPC = cerebral performance categories; GOS-E = expand the Glasgow outcome scale score; mRS = Modified Rankin Scale. IQR = interquartile range.

MRI parameters of each study are presented in [Table 2](#pone.0226295.t002){ref-type="table"}. Briefly, a 1.5-T MRI scanner was used in 15 studies, a 3.0-T MRI scanner was used in 3 studies and both scanners were used in another 9 studies ([Table 2](#pone.0226295.t002){ref-type="table"}). In the final study, the type of scanner was unclear. With respect to b-values in the DWI, a single b-value of 1000 s/mm^2^ was used in 9 studies; b-values of both 0 s/mm^2^and 1000 s/mm^2^ were used in 15 studies. The b-value(s) used were unclear in the remaining 4 studies. The mean elapsed interval between MRI and HIBI ranged from 2 hours to 13 days ([Table 2](#pone.0226295.t002){ref-type="table"}). Further, among the 28 studies, 15 studies used qualitive MRI-positive indices for their analysis, 10 studies used a quantitative index, 1 study used both and the final 3 studies used a semi-quantitative index \[[@pone.0226295.ref040], [@pone.0226295.ref050], [@pone.0226295.ref054]\]. Within the same study, multiple sets of data were considered as different DWI-positive indices. Therefore, we had 98 data subsets for meta-analysis ([Table 2](#pone.0226295.t002){ref-type="table"}).

10.1371/journal.pone.0226295.t002

###### Characteristics of the imaging protocol of the enrolled studies.
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  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                  Elapsed interval        Field\        b-value\    Positive Index                                                                       Sensitivity   Specificity
                                                 strength      (s/mm^2^)                                                                                                      
  ---------------------- ----------------------- ------------- ----------- ------------------------------------------------------------------------------------ ------------- -------------
  **Barrett,2007**       72 h (IQR,22--229)      1.5T          1000s       DWI abnormalities                                                                    0.700         0.750

  **Bevers,2018**        4 (IQR 3--5)            N/A           N/A         whole brain ADC signal intensity                                                     0.191         1.000

                                                                           15% total brain volume with ADC signal intensity \< 650 mm^2^/s                      0.362         1.000

  **Choi,2010**          52.9h ± 37.5            1.5T          0 /1000s    mixed pattern of brain injury                                                        0.769         0.923

                                                                           mean ADC value of\                                                                   0.714         1.000
                                                                           frontal cortex                                                                                     

                                                                           parietal cortex                                                                      0.857         1.000

                                                                           temporal cortex                                                                      0.643         1.000

                                                                           occipital cortex                                                                     0.929         1.000

                                                                           precentral cortex                                                                    0.857         1.000

                                                                           postcentral cortex                                                                   0.714         1.000

                                                                           caudate nucleus                                                                      0.643         1.000

                                                                           putamen                                                                              0.929         1.000

                                                                           thalamus                                                                             0.857         1.000

  **Choi,2018**          3h                      1.5 T         0/1000s     HSI on early DWI                                                                     0.909         1.000

  **Cronberg,2011**      106h(IQR93-118)         1.5T or 3T    0 /1000s    extensive brain injury                                                               0.579         1.000

  **Els,2004**           16 h (4--32)            1.5T          N/A         multiple cortical areas abnormalities                                                1.000         1.000

  **Greer,2012**         48 h (IQR 0--10h)       1.5T          0 /1000s    any imaging abnormality                                                              0.985         0.462

                                                                           basal ganglia abnormalities                                                          0.791         0.692

                                                                           cortical abnormalities                                                               0.955         0.462

                                                                           cerebellar abnormalities                                                             0.612         0.538

  **Greer,2013**         48 h (IQR 0--10h)       1.5T          0 /1000s    bilateral hippocampal hyperintensities                                               0.273         1.000

  **Heradstveit,2011**   3h                      1.5T          0 /1000s    DWI abnormalities                                                                    0.000         1.000

                         32h                                               DWI abnormalities                                                                    1.000         1.000

                         96h                                               DWI abnormalities                                                                    1.000         1.000

  **Hirsch,2015**        77h (IQR58-144h)        1.5T          0/ 1000s    qualitative MRI scoring system                                                       0.600         1.000

                                                                           DWI score (25\~192h)                                                                 0.725         1.000

  **Hirsch,2016**        69 h± 25                1.5T          0 /1000s    \>10% Brain volume with ADC\<650x10^−6^ mm^2^/s                                      0.717         0.909

                                                                           \>22% Brain volume with ADC\<650x10^−6^ mm^2^/s                                      0.522         1.000

  **Jarnum,2009**        123 h (39--251h)        1.5T or 3T    0 /1000s    diffuse signal abnormalities                                                         0.824         1.000

  **Jeon,2017**          175(117.5--240)min      1.5 T         1000s       positive high signal on DW-MRI                                                       0.813         1.000

  **Kim,2012**           45.8h(IQR,36.8--52.4)   3.0T          1000s       ADC value of frontal cortex                                                          0.625         1.000

                                                                           parietal cortex                                                                      0.656         1.000

                                                                           temporal cortex                                                                      0.563         1.000

                                                                           occipital cortex                                                                     0.906         1.000

                                                                           precentral cortex                                                                    0.656         1.000

                                                                           postcentral cortex                                                                   0.719         1.000

                                                                           caudate nucleus                                                                      0.469         1.000

                                                                           putamen                                                                              0.781         1.000

                                                                           thalamus                                                                             0.625         1.000

                                                                           cerebellum                                                                           0.563         1.000

                                                                           pons                                                                                 0.469         1.000

  **Kim,2013**           46 h (IQR,37--52)       3.0T          1000s       MCS of frontal region                                                                0.700         1.000

                                                                           occipital region                                                                     0.900         1.000

                                                                           parietal region                                                                      0.825         1.000

                                                                           rolandic region                                                                      0.800         1.000

                                                                           temporal region                                                                      0.625         1.000

                                                                           BG region                                                                            0.750         1.000

                                                                           LMEAN of frontal region                                                              0.650         1.000

                                                                           occipital region                                                                     0.625         1.000

                                                                           parietal region                                                                      0.625         1.000

                                                                           rolandic region                                                                      0.725         1.000

                                                                           temporal region                                                                      0.550         1.000

                                                                           BG region                                                                            0.500         1.000

                                                                           LMIN of frontal region                                                               0.725         1.000

                                                                           occipital region                                                                     0.750         1.000

                                                                           parietal region                                                                      0.825         1.000

                                                                           rolandic region                                                                      0.675         1.000

                                                                           temporal region                                                                      0.625         1.000

                                                                           BG region                                                                            0.425         1.000

  **Kim,2016**           53 h(46--72)            1.5T or 3T    N/A         mean ADC of the entire brain                                                         0.506         1.000

                                                                           median ADC of the entire brain                                                       0.494         1.000

                                                                           LADCV                                                                                0.747         1.000

                                                                           DC-LADCV                                                                             0.892         1.000

  **Luyt,2012**          11 d(7--17)             1.5 or 3.0T   N/A         mean diffusivity values in nine grey regions                                         0.837         0.875

  **Mettenburg,2016**    4d                      1.5T          1000s       diffuse pattern of restricted diffusion (diffuse brain injury)                       0.238         0.917

                                                                           diffuse pattern of gyral edema                                                       0.429         0.917

                                                                           restricted diffusion in basal ganglia (any)                                          0.667         0.917

                                                                           restricted diffusion in the hippocampi                                               0.286         1.000

  **Mlynash,2010**       80 h(IQR, 55--117)      1.5T          0 /1000s    extensive cortical lesion pattern                                                    0.800         1.000

                                                                           abnormalities in basal ganglia                                                       0.867         0.500

                                                                           abnormalities in brainstem                                                           0.200         1.000

  **Moon,2018**          17±14h                  3.0T          1000s       PV500 \> 6.25%                                                                       0.720         1.000

                         17±14h                                            PV400 \>2.50%                                                                        0.640         1.000

                         17±14h                                            Mean ADC\< = 726× 10^−6^ mm^2^/s                                                     0.440         1.000

                         77±23h                                            PV400\>1.66%                                                                         0.792         1.000

                         77±23h                                            Mean ADC\< = 627× 10^−6^ mm^2^/s                                                     0.208         1.000

  **Oren,2019**          2.9d (1\~5d)            1.5 or 3.0T   0 /1000s    abnormalities on DWI/ADC                                                             0.815         0.545

  **Park,2015**          2h (1.5--3.3h)          1.5T          0/1000s     overall qualitative DWI scores                                                       1.000         1.000

                                                                           DWI scores of Cortex                                                                 0.917         1.000

                                                                           DWI scores of Cortex + DGN                                                           1.000         1.000

  **Reynolds,2017**      4d (IQR3-6)             1.5 or 3.0T   1000s       ≥2.8% diffusion restriction of the entire brain at an ADC of ≤650 × 10^−6^ mm^2^/s   0.682         1.000

                                                                           ADC changes in the thalamus at an ADC threshold of ≤650 × 10^−6^ mm^2^/s             0.183         1.000

  **Ryoo,2015**          2.0d \[1.0--3.0\]       1.5 or 3.0T   1000s       positive DWI finding or regional brain injury of frontal cortex                      0.729         0.963

                                                                           parietal                                                                             0.814         0.963

                                                                           temporal                                                                             0.686         0.981

                                                                           occipital                                                                            0.771         0.963

                                                                           basal ganglia or thalamus                                                            0.466         1.000

                                                                           cerebellum                                                                           0.314         1.000

                                                                           brain stem                                                                           0.025         1.000

                                                                           MRI positive finding                                                                 0.864         0.926

  **Topcuoglu,2009**     136.8h±108              1.5T          1000s       extensive cortical lesion pattern                                                    0.875         1.000

  Velly,2018             13d(7-18d)              1.5 T or 3T   0 /1000s    FLAIR-DWI overall score                                                              0.402         1.000

                                                                           FLAIR-DWI cortex score                                                               0.333         1.000

                                                                           FLAIR-DWI cortex plus deep grey nuclei score                                         0.368         1.000

  **Wallin,2018**        4 d(IQR,4--5)           1.5 T or 3T   0 /1000s    acute hypoxic-ischemic lesions                                                       0.773         0.625

  **Wijdicks,2001**      144h (24\~360)          1.5T          0 /1000s    diffuse signal abnormalities                                                         1.000         1.000

  **Wijman,2009**        49--108h                1.5T          0 /1000s    \>10% brain volume with ADC\<650x10^−6^ mm^2^/s                                      0.810         1.000

  **Wu,2009**            2d (IQR 0--10d)         1.5T          0 / 1000s   whole-brain median ADC                                                               0.409         1.000
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Note:** DC-LADCV = the relative volume of the dominant (biggest) cluster of the low-ADC voxels. HIS = high signal intensity; LADCV = the relative volume of voxels with ADC values less than the predefined ADC threshold; LMEAN = lowest mean ADC; LMIN = lowest minimum ADC; MCS = Maximum cluster size; PV = % voxels with ADC values below the predefined ADC thresholds.

In 21 studies, MRI analyses were performed in a blinded manner. In one study, the investigators were not blind to the examined groups and it was not indicated in the remaining 6 studies. For ethical reasons, the image analysts were blinded to clinical information and outcome in 21 studies, but the clinical treatment team was blinded to the imaging analysis results in only 3 studies \[[@pone.0226295.ref022], [@pone.0226295.ref045], [@pone.0226295.ref054]\]. Further, it is worth mentioning that all of the examined studies had a relatively small study population which may affect the reliability of the results obtained in the current work. Therefore, we performed a quality assessment test using the QUADAS-2 tool ([Fig 2](#pone.0226295.g002){ref-type="fig"}, [S1 Fig](#pone.0226295.s002){ref-type="supplementary-material"}). Among the 28 studies, 13 studies demonstrated patient selection bias risk and applicability concerns. With regards to the index test, a total of 8 studies had bias risk; while 8 studies had applicability concerns ([Fig 2](#pone.0226295.g002){ref-type="fig"}, [S1 Fig](#pone.0226295.s002){ref-type="supplementary-material"}).

![Evaluation of the included studies using Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool.\
Bias risk and applicability concerns were analyzed in all studies and categorized into high (red), low (green) and unclear (yellow).](pone.0226295.g002){#pone.0226295.g002}

Diagnostic performance {#sec008}
----------------------

The overall sensitivity and specificity were 0.613 (95% CI, 0.599--0.628) and 0.958 (95% CI, 0.947--0.967), respectively ([Fig 3A and 3B](#pone.0226295.g003){ref-type="fig"}). In the SROC analysis, the AUC and Q-index were 0.9090 and 0.8410, respectively, thereby, indicating a good diagnostic accuracy ([Fig 3C](#pone.0226295.g003){ref-type="fig"}). For individual studies, the sensitivity ranged from 2.5% to 100%, and their specificity ranged from 46% to 100%. These results indicate a significant heterogeneity among the examined studies ([Fig 3A and 3B](#pone.0226295.g003){ref-type="fig"}).

![Diagnostic performance of the included studies.\
A,B: Forest plot demonstrating the sensitivity and specificity of individual studies arranged in alphabetical order. C Summary receiver operating characteristic (SROC) curve, D Receiver operating characteristic (ROC) plane respectively. CI: confidence intervals.](pone.0226295.g003){#pone.0226295.g003}

Assessment of study heterogeneity {#sec009}
---------------------------------

A significant heterogeneity was detected in the sensitivities and specificities of the included studies (*P \< 0*.*001*). The ROC curve demonstrated a "shoulder-arm" shape indicative of a threshold effect ([Fig 3D](#pone.0226295.g003){ref-type="fig"}). Additional analysis revealed a significant linear correlation between the logit of sensitivity and the logit of (1---specificity) (r = 0.539, P \< 0.001), thereby, confirming a threshold effect which resulted in the notable heterogeneity. This led us to hypothesize that different positive indices (cutoff values) were the major source of heterogeneity.

Next, we explored other factors that can cause heterogeneity via meta-regression analysis using the following predictor variables: study type (prospective or retrospective), patient category (OHCA or IHCA), hypothermia treatment (present/absent), poor outcome definition, timeframe for outcome assessment, study bias (blinding), elapsed time until brain MRI, field strength, b-value, test index (qualitative or quantitative), and the examined brain region. The patient category, test index and the examined brain region were selected by multivariate meta-regression analysis as significant predictor variables that can affect heterogeneity.

Subgroup analysis {#sec010}
-----------------

Next, we carried out a subgroup analysis on the different study subsets ([Table 3](#pone.0226295.t003){ref-type="table"}). Among the examined brain regions, the cortical region had the highest diagnostic accuracy, followed by the basal ganglia region (moderate diagnostic accuracy). While, the other brain regions (cerebellum, brain stem, and hippocampus) showed low diagnostic accuracy (P = 0.0049). Interestingly, the diagnostic accuracy was similar when scanning the cortical regions only and the whole brain.

10.1371/journal.pone.0226295.t003

###### Subgroup analysis among the different study subsets.

![](pone.0226295.t003){#pone.0226295.t003g}

  ------------------------------------------------------------------------------------------------------------------
  Study characteristics         No of subsets   Pooled sensitivity(95% CI)   Pooled specificity(95% CI)   P
  ----------------------------- --------------- ---------------------------- ---------------------------- ----------
  **Total**                     98              0.613(0.599--0.628)          0.958(0.947--0.967)          

  **Region measured**                                                                                     0.0049

  **Global**                    33              0.611(0.587--0.636)          0.951(0.93--0.966)           

  **Cortex**                    41              0.712(0.689--0.733)          0.973(0.958--0.984)          

  **Basal Ganglia**             16              0.582(0.541--0.623)          0.928(0.888--0.958)          

  **Others**                    8               0.301(0.259--0.344)          0.968(0.931--0.988)          

  **Index test**                                                                                          0.0018\
                                                                                                          (0.0009)

  **qualitive**                 32              0.635(0.612--0.659)          0.904(0.880--0.925)          

  **quantitive**                56              0.628(0.608--0.648)          0.995(0.987--0.999)          

  **Semi-quantitive(all)**      10              0.472(0.427--0.518)          1.000(0.984--1.000)          

  **Semi-quantitive(\<7d)**     7               0.739(0.658--0.810)          1.000(0.973--1.000)          

  **Time of MRI examination**                                                                             0.1426

  **\~1d**                      9               0.767(0.694--0.829)          1.000(0.960--1.000)          

  **2\~6d**                     85              0.627(0.611--0.642)          0.953(0.941--0.963)          

  **\>6d**                      4               0.425(0.376--0.475)          0.991(0.949--1.000)          

  **OHCA or IHCA**                                                                                        0.0001

  **OHCA**                      53              0.646(0.627--0.665)          0.984(0.973--0.991)          

  **IHCA or MIX**               45              0.566(0.543--0.589)          0.925(0.903--0.942)          

  **Co-index**                                                                                            0.0008

  **DWI**                       98              0.613(0.599--0.628)          0.958(0.947--0.967)          

  **co-index**                  6               0.862(0.823--0.895)          1.000(0.977--1.000)          
  ------------------------------------------------------------------------------------------------------------------

**Note:** OHCA = out-of-hospital cardiac arrest; Mix = OHCA or IHCA (in-hospital cardiac arrest)

The pooled data revealed that qualitative and quantitative analysis methods had a similar diagnostic accuracy, while the semi-quantitative analysis had lower diagnostic accuracy (P = 0.0018) \[[@pone.0226295.ref040], [@pone.0226295.ref050], [@pone.0226295.ref054]\]. Interestingly, the elimination of Velly et al.\[[@pone.0226295.ref054]\], in which the DWI examination was performed 6 days after onset (7--18 day), from semi-quantitative group can change the significance of the results. Specifically, the diagnostic accuracy of semi-quantitative group would have been significantly better than that of the qualitive or quantitative index within the first 7 days after HIBI (p = 0.0008).

Further, the MRI examination time is also an important factor affecting the diagnostic accuracy except for test index. The analysis of different time points demonstrated that the diagnostic accuracy of DWI within 6 days of onset was higher than that of after 6 days, but it did not reach statistical significances (p = 0.1426). Moreover, the imaging diagnostic accuracy was higher in the OHCA patients than the IHCA or mixed (OHCA/IHCA) patients (P = 0.0001).

Furthermore, we observed that DWI imaging indices combined with other predictors (co-index) like brain CT\[[@pone.0226295.ref041]\], EEG\[[@pone.0226295.ref034]\], motor response\[[@pone.0226295.ref034], [@pone.0226295.ref040]\] or other MRI modalities \[[@pone.0226295.ref054]\] produced significantly improved diagnostic accuracy ([Table 3](#pone.0226295.t003){ref-type="table"}; P = 0.0008).

Publication bias {#sec011}
----------------

There was no evidence of publication bias (P = 0.19) as revealed by the symmetric distribution of diagnostic odds ratio against (effective sample size)^-1/2^([S2 Fig](#pone.0226295.s003){ref-type="supplementary-material"}).

Discussion {#sec012}
==========

In this study, we analyzed the efficiency of DWI in predicting a poor outcome of HIBI. Our meta-analysis results demonstrated that DWI is an accurate imaging tool for predicting HIBI outcome with high specificity (95.9%). On the other hand, individual studies showed significant heterogeneity in terms of sensitivity and specificity. This heterogeneity was primarily attributed to the threshold effect, in addition to the test index, the region imaged and the patients' categorization (OHCA or IHCA). The different imaging protocols, signal characteristics and anatomic regions measured accounted for different positive indices which affected the overall imaging diagnostic accuracy.

Our meta-analysis results indicated that the diagnostic accuracy varied substantially according to the region being assessed. The cortical region demonstrated the highest diagnostic accuracy, followed by the basal ganglia with moderate accuracy. Therefore, DWI signal abnormalities or ADC reduction can be significantly influenced by the anatomical region examined. Several studies showed that DWI signal abnormalities or ADC reduction were also time dependent \[[@pone.0226295.ref021], [@pone.0226295.ref035], [@pone.0226295.ref047]\]. In poor-outcome patients, Mlynash et al. confirmed that cortical structures exhibited the most profound ADC reductions, which were observed as early as 1--2 days after the HIBI and reached a nadir 3--5 days after the HIBI. Therefore, Wijman et al proposed that the ideal prognostic window is between 49 and 108 hours after HIBI \[[@pone.0226295.ref019]\]. Our subgroup analysis also showed that diagnostic accuracy during the 6 days that follows HIBI was higher than that after the 6 days period. Interestingly, the diagnostic accuracy during the first 24 hours after HIBI was not less stringent than other studies acquiring the results of DWI during the ideal prognostic window. This could be attributed to the use of sensitive indicators, like abnormal high signal presence on DW-MRI during the acute window rather than extensive abnormality.

Since MRI signal is affected by the region and time of detection, it is particularly important to select an appropriate diagnostic strategy and index. Typically, post-ischemic MRI images display cortical or basal ganglia hyperintensity in DWI sequences \[[@pone.0226295.ref056], [@pone.0226295.ref057]\]. Following HIBI, the presence of large or extensive multilobar alterations on DWI MRI images has been correlated with poor outcome \[[@pone.0226295.ref058]\]. The apparent diffusion coefficient (ADC) value has been widely used to quantitatively assess the progression of ischemia when using DWI. In HIBI, several ADC methods, such as determining the whole-brain ADC value, quantifying the region with low ADC, or calculating the lowest ADC value in a specific brain area have been previously used to predict patient outcomes \[[@pone.0226295.ref021], [@pone.0226295.ref043], [@pone.0226295.ref047]\]. However, we observed that different research centers used different predictors. Therefore, there was a lack of clear and generally accepted positive indices, especially for the quantitative indices. Consequently, it was difficult for those indicators to be widely applied among the different research centers. In agreement, the 2015 guidelines of the European Society of Intensive Care Medicine and European Resuscitation Council also highlighted the limitations of studies using MRI to prognosticate following HIBI; noting the lack of homogeneity in radiological definitions of imaging findings \[[@pone.0226295.ref011]\]. Thus, there is a need for a specific DWI index that can be used concisely in the clinic.

The semi-quantitative method (qualitative MRI scoring system) has been successfully developed as a tool to predict the outcome following perinatal asphyxia, and has been reported to provide an accurate index for HIBI severity following postanoxic coma \[[@pone.0226295.ref040], [@pone.0226295.ref059]\]. Our study showed that qualitative brain MRI scoring system was also good for predicting the outcome of the HIBI and may be an ideal DWI index for clinical use. Future well-designed, large-scale studies should be carried out to confirm the best positive index. The combination of qualitative and quantitative methods, or machine-based auto-analysis can be potential directions for future studies.

Although DWI could predict the outcome of HIBI with good prognostic accuracy, there are still several limitations of solely depending on it. Guidelines from professional societies advocated neuroimaging was recommended only in combination with other predictors \[[@pone.0226295.ref011]\]. Our pooled data also showed that DWI examination combined with other predictors could improve diagnostic accuracy \[[@pone.0226295.ref034], [@pone.0226295.ref040], [@pone.0226295.ref041], [@pone.0226295.ref054]\]. Therefore, the integration of DWI data with other prognostic markers such as serial neurological assessments, physiological tests, serum marker levels or other model MRI examination in the future could be instrumental for the prediction of HIBI outcome. This model will ultimately affect the patients' care strategies.

In conclusion, in this study we performed a systemic review and meta-analysis to assess the ability of DWI in predicting poor outcome in HIBI. Our results indicated that DWI can accurately predict the poor outcome of HIBI. Nevertheless, this meta-analysis had various limitations. First, patients with implanted devices like pacemakers or implantable cardioverter defibrillators (ICDs), or other metallic objects could not undergo the conventional MRI. For example, only 21/514 (4.1%) cardiopulmonary arrest survivors underwent subsequent brain MRIs, which may reflect a patient selection bias \[[@pone.0226295.ref033]\]. However, this issue was resolved in more recent studies \[[@pone.0226295.ref019], [@pone.0226295.ref040]\].

Second, our meta-analysis included different populations, like OHCA or IHCA patients, or patients who did or did not undergo hypothermia treatment (and the reporting of outcome assessment and the timeframe thereof), and reflects a wide variability in case characteristics. In addition, the strategies for active treatment withdrawal differed between studies. These differences can partly be responsible for the heterogeneity of our results.

Third, the retrospective nature of 14 from the 28 included studies, the relatively small sample size in each individual study and the absence of proper blinding measures in almost all studies (25/28) could have led to studies with a low quality of evidence. Further, the exclusion of non-English articles could have limited the strength of our meta-analysis. Therefore, future research should include more studies to confirm our results and evaluate the predictive value of DWI in global brain anoxia.

Conclusion {#sec013}
==========

Our meta-analysis demonstrated that DWI can accurately predict the outcome of HIBI. However, the diagnostic accuracy is influenced by the region measured and time of MRI acquisition. Furthermore, the lack of clear and generally accepted positive indexes limits its clinical application. The use of a more reliable positive index and combining DWI with other predictors may help to improve the accuracy of diagnosis.

Supporting information {#sec014}
======================

###### PRISMA checklist.

(DOC)

###### 

Click here for additional data file.

###### Risk of bias and applicability concerns summary.

Review authors\' judgements about each domain for each included study.

(TIF)

###### 

Click here for additional data file.

###### DEEKS funnel analysis to assess the publication bias.

(TIFF)

###### 

Click here for additional data file.

10.1371/journal.pone.0226295.r001

Decision Letter 0

Lazzeri

Chiara

Academic Editor

© 2019 Chiara Lazzeri

2019

Chiara Lazzeri

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

2 Sep 2019

PONE-D-19-17572

Prediction of neurological outcome after hypoxic-ischemic brain injury by diffusion-weighted imaging: A systematic review and meta-analysis

PLOS ONE

Dear Dr. Luo,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Oct 17 2019 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Chiara Lazzeri

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Partly

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: No

Reviewer \#2: I Don\'t Know

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: No

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The authors investigated an interesting topic that can have relevant clinical meaning. The methodology is accurate and rigorous. But I have concerns regarding many points that I will detail below.

The first point is that I am very puzzled in the statistical analysis, because if each author has chosen different cut-offs to get 100% specificity hat is FPR = 0 it cannot be said that the specificity of the method is this and not very variable. The analysis shows in fact that there is no shared index and that each author has decided his own, therefore the negativity of other cofactors in conditioning the specificity and a false deduction The conclusion of the work that can be deduced is that each work used different indices, whereas I would prefer to see cumulative analysis of homogeneous set of data. For example It is well known that MRI findings changes truough the time, so diffent index can be usefult at different time, so the specificity is not of the MRI but of index and Is time dependent.

More in details

Title: according to the results please add in the title "poor"

Abstracts: "explicit" please find a synonymous.

Please use prognostic instead of diagnostic

Introduction:

pg 3:

"disease modifying agents" this definition is not appropriate for HIE,

"normothermia phase which render the prognostic predictors less reliable\[7\]." This is not true, please have a loo to recent Bibliography, such as Scarpino et al., 2018, Resuscitation

pg 4: developing a more accurate assessment of acute-stage HIBI patients is urgently needed.: I do not agree with these, because performing MRI is not possible usually in the first 24 hours

Nevertheless, CT and conventional MRI frequently underestimate the degree of brain injury in acute HIBI \[12: being a systematic review I think not appropriate referring to a reference of 1999.

Methods

Pg 4:

In this study, we performed a comprehensive literature research in PubMed, EMBASE, and the Cochrane Library databases for DWI from January 1995 to December 2018.: this point seems to be very illogical for two mean reasons 1) TTM have been introduced about 2002 2) DWI is not a technique introduced so early. Actually only one reference is dated 2001.

Pg 5: The outcome was classified into poor and good according to the CPC scores (3-4 or 4-5 versus1-2 or 1-3, respectively). Alternatively, we classified the outcomes into CPC 4--5 versus 1--3, if the CPC thresholds were not defined.

Please clarify this point, the authors extrapolate the data from the table presented by authors according to the cut off they used. I do not agree to attribute a priori a cut off if this is not specified and the studies not reporting clear indication should be not considered in the analysis.

Table 2: I'm very surprised to find in the table studies in which idex test has specificity and sensitivity of 100%. He authors reviewed the quality of the study and how can include these studies in their computation?

DISCUSSION

PG 17

"Given this finding, the semi-quantitative method was used by only 2 studies"

Please rephrase this sentence, this is a systematic review, not an original paper reporting data about a sample of patients.

PG 18

"Further, during brain damage, Wu et al., demonstrated an initial ADC reduction in the striatum and thalamus, followed by the cortex and the subcortical white matter. This DWI pattern could be an indication of ongoing tissue damage due to secondary apoptotic processes, and thus various brain structures can respond differently to ischemic injury \[22\]."

This sentence is not useful, in this kind of paper the authors should report consideration about cumulative data, is not a narrative report.

Pg 18-19

"However, our pooled analysis did not demonstrate that sensitivity and specificity of DWI were time dependent. The meta-regression analysis showed that the elapsed time between HIBI and brain MRI examination was not a factor in heterogeneityInterestingly, their diagnostic accuracy was not less stringent than other studies acquiring the DWI data during the ideal time window. This suggests that the time of the MRI is not an important factor in determining diagnostic accuracy.
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Response to reviewer \# 1

1- Title: according to the results please add in the title "poor"

Response to reviewer: Thanks for your suggestion. We revised the title as recommended "Prediction of poor outcome after hypoxic-ischemic brain injury by diffusion-weighted imaging: A systematic review and meta-analysis"

2- Abstracts: "explicit" please find a synonymous.

Response to reviewer: Thanks for your comment. We replaced "explicit" by "clear and generally accepted" in the revised abstract.

3- Please use prognostic instead of diagnostic

Response to reviewer: Thanks for your comment. We used "prognostic" instead of "diagnostic" in the revised manuscript.

4- Introduction:

A- pg 3:

"disease modifying agents" this definition is not appropriate for HIE,

Response to reviewer: Thanks for your comment. We deleted this phrase in the revised manuscript (page 3, lines20-21).

B- "normothermia phase which render the prognostic predictors less reliable\[7\]." This is not true, please have a loo to recent Bibliography, such as Scarpino et al., 2018, Resuscitation

Response to reviewer: Thanks for your comment. We agree, low doses of sedatives and therapeutic hypothermia (TTM) had limited effects on cortical SEP components and/or the EEG (Scarpino, Lanzo et al. 2018). However, according to European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for Post-resuscitation Care 2015, both TTM itself and sedatives or neuromuscular blocking drugs used to maintain it may potentially interfere with prognostication indices, especially those based on clinical examination (Nolan JP et al, 2015, Resuscitation). We rewrote this statement to make it clearer in the revised version of our manuscript (page 3, lines20-21).

C- pg 4: developing a more accurate assessment of acute-stage HIBI patients is urgently needed.: I do not agree with these, because performing MRI is not possible usually in the first 24 hours.

Response to reviewer: Thanks for your comment. Obtaining a brain MRI in critically-ill patients with potential cardiac instability may be challenging during the acute-stage (Wijdicks, Campeau et al. 2001). We agree that using the word "acute"may be not appropriate. Therefore, we used the term "early-stage" instead of "acute-stage". However, we believe that the development of advanced equipment will enable the use of MRI examination at earlier HIBI stages.

D- Nevertheless, CT and conventional MRI frequently underestimate the degree of brain injury in acute HIBI \[12: being a systematic review I think not appropriate referring to a reference of 1999.

Response to reviewer: Thanks for your suggestion. We updated the relevant literature.

5- Methods

A- Pg 4:

In this study, we performed a comprehensive literature research in PubMed, EMBASE, and the Cochrane Library databases for DWI from January 1995 to December 2018.: this point seems to be very illogical for two mean reasons 1) TTM have been introduced about 2002 2) DWI is not a technique introduced so early. Actually only one reference is dated 2001.

Response to reviewer: Thanks for your comment. The clinical application of DWI for ischemic brain injury began in the 1990s (Fisher, Prichard et al. 1995, Schabitz and Fisher 1995). In our preliminary search, we found that the first study reporting the application of DWI in global cerebral ischemia was published in 1999 (Arbelaez, Castillo et al. 1999) Therefore, for the comprehensiveness of our search, we set the beginning time as 1995 and this did not influence our results.

Regarding TTM treatment, subjects included in our analysis were not limited to patients receiving TTM treatment. In fact, all eligible subjects with hypoxic--ischemic brain injury were included in this study regardless they received TTM treatment or no. I hope this explanation clarifies our point of view.

B- Pg 5: The outcome was classified into poor and good according to the CPC scores (3-4 or 4-5 versus1-2 or 1-3, respectively). Alternatively, we classified the outcomes into CPC 4--5 versus 1--3, if the CPC thresholds were not defined.

Please clarify this point, the authors extrapolate the data from the table presented by authors according to the cut off they used. I do not agree to attribute a priori a cut off if this is not specified and the studies not reporting clear indication should be not considered in the analysis.

Response to reviewer: Thanks for your comment. Among the enrolled studies, the cutoff value was not defined in only one study (Wijdicks, Campeau et al. 2001). In that study, the outcome for each patient was recorded for analysis. On the other hand, cut off values were defined in all the remaining studies. Therefore, we were able to define the prognostic results for each patient and thus our definition of CPC 4--5 as poor outcome was based on the results reported by the original authors.

In order to obtain more reliable results, we set more stringent inclusion criteria for this research by excluding studies that involved less than 10 patients. Therefore, we excluded three small studies and thus the above statement was deleted. (p5, line 21)

C- Table 2: I'm very surprised to find in the table studies in which idex test has specificity and sensitivity of 100%. He authors reviewed the quality of the study and how can include these studies in their computation?

Response to reviewer: Thanks for your comment. According to our inclusion and exclusion criteria, we initially enrolled 29 observational cohort studies for our final analysis, which included 13 prospective studies and 16 retrospective studies. All 16 retrospective studies were cohort studies and the data of 6 out of those 16 studies were prospectively collected and retrospectively analyzed.

To update our data, we re-searched the databases (PubMed, EMBASE, and the Cochrane Library databases) from January 1995 to September 2019, and set more stringent inclusion criteria for our analysis (i.e., studies with less than 10 patients were excluded). Accordingly, we found two additional studies (Velly, Perlbarg et al. 2018, Oren, Chang et al. 2019) and removed three original studies from the literature research due to the small number of cases (Wijdicks, Campeau et al. 2001, Heradstveit, Larsson et al. 2011, Choi, Youn et al. 2012). Next, we analyzed the diagnostic results (i.e. the true-positive, false-positive, false-negative, and true-negative results) for calculating their sensitivity and specificity. Finally, we observed that the main conclusion was still the same with our previous analysis. This further confirms the consistency of our results. The updated analysis has been included in the revised manuscript.

7- DISCUSSION

A- PG 17

"Given this finding, the semi-quantitative method was used by only 2 studies"

Please rephrase this sentence, this is a systematic review, not an original paper reporting data about a sample of patients.

Response to reviewer: We updated the data and revised this sentence (page 17 lines 13-20 of the revised manuscript).

B- PG 18

"Further, during brain damage, Wu et al., demonstrated an initial ADC reduction in the striatum and thalamus, followed by the cortex and the subcortical white matter. This DWI pattern could be an indication of ongoing tissue damage due to secondary apoptotic processes, and thus various brain structures can respond differently to ischemic injury \[22\]."

This sentence is not useful, in this kind of paper the authors should report consideration about cumulative data, is not a narrative report.

Response to reviewer: Thanks for your suggestion, we deleted this sentence and rewritten the relevant paragraph (page 16, lines 1-4 of the revised manuscript).

C- Pg 18-19

"However, our pooled analysis did not demonstrate that sensitivity and specificity of DWI were time dependent. The meta-regression analysis showed that the elapsed time between HIBI and brain MRI examination was not a factor in heterogeneity Interestingly, their diagnostic accuracy was not less stringent than other studies acquiring the DWI data during the ideal time window. This suggests that the time of the MRI is not an important factor in determining diagnostic accuracy.

This is an example of what I have underlined in the first part of my comments; this results is true if we evaluated the value of specificity, in this case 100%, but this finding would be right only if in all the paper the authors had used the same parameters to reach the best predictive power at every window. In fact the studies reported by the authors \[20, 38, 44, 48, 51, 52\] all used different measure od MRI , so the message that time dependence of MRI is not a factor is not true. MRI is a time dependent test and for every time frame require different measure to reach the best predicitve power.

Response to reviewer: Thanks for your important comment. We re-searched the databases (PubMed, EMBASE, and the Cochrane Library databases) from January 1995 to September 2019. We included 2 new studies (Velly, Perlbarg et al. 2018, Oren, Chang et al. 2019), and excluded three original because of the small number of cases (Wijdicks, Campeau et al. 2001, Heradstveit, Larsson et al. 2011, Choi, Youn et al. 2012). Our subgroup analysis showed that diagnostic accuracy during 6 days after HIBI was higher than that after 6 days, although our meta-regression analysis showed that the elapsed time between HIBI and brain MRI examination was not a factor in heterogeneity (Table 1). Interestingly, the diagnostic accuracy during the first 24 hours after HIBI was not less stringent than the other studies acquiring the DWI data during days 2 to 6. This does not contradict the previous conclusion that DWI signal abnormalities were time dependent, because those studies used different diagnostic strategy and criteria (Hirsch, Mlynash et al. 2015, Park, Lee et al. 2015). Although DWI signals were time-dependent but, different diagnostic strategies could be used to improve the accuracy of diagnosis. It is worth mentioning that the diagnostic accuracy of DWI will significantly decrease if the examination period exceeds 7 days. We revised the manuscript accordingly (page16, lines 4-15).

Table 1. Subgroup analysis among the different study subsets.

Study characteristics No of subsets Pooled sensitivity(95 % CI) Pooled specificity(95 % CI) P

Total 98 0.613(0.599-0.628) 0.958(0.947-0.967)

Time of MRI examination 0.1426

\~1d 9 0.767(0.694-0.829) 1.000(0.960-1.000)

2\~6d 85 0.627(0.611-0.642) 0.953(0.941-0.963)

\>6d 4 0.425(0.376-0.475) 0.991(0.949-1.000)

D- PG 19

"Therefore, DWI examination could be carried out in a wider timeframe than other prognostic strategies like clinical examination, myoclonus and status myoclonus, electroencephalogram, or biomarkers"

Again this is not completely true, EEG and SEP can be performed in any time windows, and offer also the advantage to be more available in every clinical setting, can be recorded bed-side and repeated more time.

Response to reviewer: Thanks a lot. We agree, and we rewritten the paragraph accordingly (page 16, lines 9-21; page 17, lines 1-12 )

8- CONCLUSION

They need to be completely rephrased according to the revised version of the manuscript according to the point raised.

Response to reviewer: Thanks for your valuable suggestions. We rewritten this paragraph accordingly in the revised version (pages 19, lines 9-13).

Response to reviewer \#2

1- In my opinion, the authors have performed many statistical tests, but with limited adjustments to the clinical, technical and pathofysiological background of the DWI analyses. Although the tests may be carried out correctly, their applicability is limited in the current form of the manuscript. I therefor asked the authors to adjust the manuscript more towards clinical use.

Response to the reviewer：Thanks for suggestion. In order to make this manuscript more comprehensive and reliable for clinicians, we re-searched the databases (PubMed, EMBASE, and the Cochrane Library databases) from January 1995 to September 2019, and set more stringent inclusion criteria for our analysis. Studies that involved less than 10 patients were excluded. Accordingly, we included two additional studies (Velly, Perlbarg et al. 2018, Oren, Chang et al. 2019) and removed three original studies from the literature research due to the small number of cases (Wijdicks, Campeau et al. 2001, Heradstveit, Larsson et al. 2011, Choi, Youn et al. 2012). We re-analyzed the included data, then added new statements and revised the discussion section to make the manuscript more informative for clinicians.

In 2015 , the European Society of Intensive Care Medicine and European Resuscitation Council (Nolan JP, et al，Resuscitation, 2015.) highlighted the limitations of studies using MRI after HIBI. The lack of homogeneity in radiological definitions of imaging findings and neuroimaging caused this drawback. Our review focused on DWI research and it included recently published studies to help clinicians make informed decisions based on the summary of studies performed in the last 25 years. Further, we added meta-regression and subgroup analysis to explain the limitations of the enrolled studies thus, providing a more accurate theoretical basis for the clinical analysis and judgment.

2- The authors chose to pool studies of different study desings in one meta-analyses. I answerd \"partly\" on question one, since I am not convinced that this is appropriate for the current study.

Response to reviewer：Thanks for suggestion again. According to our inclusion and exclusion criteria, we initially enrolled 29 observational cohort studies for our final analysis which included 13 prospective studies and 16 retrospective studies. All 16 retrospective studies were cohort studies, and data of 6/16 studies were prospectively collected and retrospectively analyzed. Our preliminary analysis suggested the absence of significant difference in the diagnostic accuracy between the prospective group and retrospective group. Therefore, we included all these observational cohort studies in our analysis.

To update our data, we also re-searched the databases and set more stringent inclusion criteria for our analysis. In addition, we also carefully checked and explored the study heterogeneity (the variability across studies). We evaluated the threshold effect of included studies at first and then we performed a meta-regression analysis and subgroup analysis to investigate factors that could possibly lead to heterogeneity and explored their possible impact on diagnostic accuracy. This is also critical for our clinical analysis and further research. (page 8, lines 4-5; p16-19).
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Thanks again for your meticulous reviews. All new amendments are written in red font color in the revised version of our manuscript. I hope the revised version is now acceptable for publication.
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